Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$1.68B |
| 2 |
Synchrony
SYF
|
+$441M |
| 3 |
Meta Platforms (Facebook)
META
|
+$370M |
| 4 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$349M |
| 5 |
Comcast
CMCSA
|
+$338M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AET
Aetna Inc
AET
|
+$783M |
| 2 |
Morgan Stanley
MS
|
+$518M |
| 3 |
Lowe's Companies
LOW
|
+$474M |
| 4 |
Visa
V
|
+$425M |
| 5 |
Netflix
NFLX
|
+$419M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 5.01% |
| 2 | Technology | 4.76% |
| 3 | Consumer Discretionary | 3.82% |
| 4 | Industrials | 3.81% |
| 5 | Communication Services | 3.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CBIO
2101
Crescent Biopharma
CBIO
$637M
| $7.54M | ﹤0.01% |
7,967
-534
| -6% | -$643K |
|
2102
PUT
Molson Coors Class B
TAP
$7.97B
| $7.54M | ﹤0.01% |
134,300
-328,200
| -71% | -$20.2M |
|
2103
PUT
Teradyne
TER
$65.5B
| $7.53M | ﹤0.01% |
240,100
+142,800
| +147% | +$4.84M |
|
|
DRE
2104
DELISTED
Duke Realty Corp.
DRE
| $7.53M | ﹤0.01% |
290,755
+2,632
| +0.9% | +$73K |
|
2105
Avient
AVNT
$4.25B
| $7.53M | ﹤0.01% |
263,088
+165,639
| +170% | +$5.54M |
|
2106
CALL
KB Home
KBH
$3.44B
| $7.52M | ﹤0.01% |
393,900
+141,400
| +56% | +$2.9M |
|
2107
CALL
Direxion Daily S&P Biotech Bull 3X ETF
LABU
$629M
| $7.52M | ﹤0.01% |
11,440
+5,315
| +87% | +$5.57M |
|
|
AAIC
2108
DELISTED
Arlington Asset Investment Corp.
AAIC
| $7.52M | ﹤0.01% |
1,038,294
+34,275
| +3% | +$288K |
|
2109
Oaktree Specialty Lending
OCSL
$1.14B
| $7.51M | ﹤0.01% |
591,900
+11,773
| +2% | +$161K |
|
2110
Webster Financial
WBS
$12.8B
| $7.51M | ﹤0.01% |
152,278
-14,314
| -9% | -$817K |
|
2111
PUT
WisdomTree Japan Hedged Equity Fund
DXJ
$7.53B
| $7.5M | ﹤0.01% |
161,600
+4,500
| +3% | +$235K |
|
2112
CALL
Alnylam Pharmaceuticals
ALNY
$30.6B
| $7.5M | ﹤0.01% |
102,800
-69,900
| -40% | -$5.38M |
|
2113
Houlihan Lokey
HLI
$8.99B
| $7.49M | ﹤0.01% |
203,397
-314,130
| -61% | -$12.8M |
|
2114
PUT
KLA
KLAC
$266B
| $7.47M | ﹤0.01% |
835,000
-310,000
| -27% | -$2.89M |
|
|
IIN
2115
DELISTED
IntriCon Corporation
IIN
| $7.46M | ﹤0.01% |
282,790
-14,604
| -5% | -$555K |
|
|
CNH
2116
CNH Industrial
CNH
$16.8B
| $7.45M | ﹤0.01% |
929,714
-231,887
| -20% | -$2.05M |
|
|
NVO
2117
CALL
Novo Nordisk
NVO
$201B
| $7.45M | ﹤0.01% |
323,400
+144,800
| +81% | +$3.22M |
|
|
CYBR
2118
CALL
DELISTED
CyberArk
CYBR
| $7.44M | ﹤0.01% |
100,400
-11,600
| -10% | -$829K |
|
|
SFLY
2119
CALL
DELISTED
Shutterfly, Inc.
SFLY
| $7.44M | ﹤0.01% |
184,900
+104,000
| +129% | +$5.46M |
|
2120
CALL
Digital Realty Trust
DLR
$74.1B
| $7.44M | ﹤0.01% |
69,800
-48,200
| -41% | -$5.33M |
|
2121
Harley-Davidson
HOG
$2.89B
| $7.43M | ﹤0.01% |
217,918
+83,836
| +63% | +$3.29M |
|
2122
Invesco
IVZ
$14.4B
| $7.43M | ﹤0.01% |
443,968
-67,078
| -13% | -$1.34M |
|
2123
PUT
Ally Financial
ALLY
$13.7B
| $7.43M | ﹤0.01% |
327,900
-10,600
| -3% | -$265K |
|
2124
MetLife
MET
$62.1B
| $7.42M | ﹤0.01% |
180,748
-90,582
| -33% | -$3.89M |
|
|
RSX
2125
DELISTED
VanEck Russia ETF
RSX
| $7.42M | ﹤0.01% |
395,834
+341,792
| +632% | +$7.02M |
|
Similar funds
Ken Griffin's Q4 2018 Portfolio in Review
As of Q4 2018, Ken Griffin held 10,385 positions worth $183B, down 19% from $224B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Ken Griffin withdrew a net $8B in Q4 2018, closing 1,371 positions and reducing 3,800 holdings. Its most notable exit was Aetna Inc, an estimated $783M position sold in full.
By sector, the portfolio is most concentrated in Financials at 5% of assets, down from 5.9% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, Ken Griffin opened a new position in Assurant worth $99.4M.
- Ken Griffin's largest Q4 2018 buy was Assurant: 1,111,342 shares worth $99.4M.
- Ken Griffin added most to Amazon in Q4 2018, an estimated $1.68B increase.
- Ken Griffin's biggest Q4 2018 reduction was Morgan Stanley, cutting an estimated $518M.
- Ken Griffin fully exited Aetna Inc in Q4 2018, selling an estimated $783M.
- Ken Griffin's ten largest holdings make up 24% of its $183B portfolio in Q4 2018.
- Ken Griffin opened 1,236 new positions and closed 1,371 in Q4 2018.
- Ken Griffin's portfolio value fell 19% quarter-over-quarter to $183B.
Based on Citadel Advisors's 13F filing for Q4 2018, filed 14 Feb 2019.